Douglas Conrad

5.5k citations

71 papers · 3.7k indexed · 1 hit paper · h-index 28

Impact in

Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Pulmonary and Respiratory Medicine top 2%
- Cystic Fibrosis Research Advances
- Tracheal and airway disorders

Papers in

Pulmonary and Respiratory Medicine 46
- Cystic Fibrosis Research Advances 39
- Neonatal Respiratory Health Research 12
- Inhalation and Respiratory Drug Delivery 11
- Tracheal and airway disorders 7
- Chronic Obstructive Pulmonary Disease (COPD) Research 7
Space and Planetary Science 1

Co-authors: Forest Rohwer Yan Wei Lim Elliott Sigal Robert Schmieder Mike Furlan Colin Funk John S. Welch Christoph J. Binder
Journals: Journal of Cystic Fibrosis (8 papers)PLoS ONE (5 papers)The ISME Journal (3 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Germany Canada

In The Last Decade

Douglas Conrad

69 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase 1999 · 749 citations

Peers

Countries citing papers authored by Douglas Conrad

Since Specialization

Citations

This map shows the geographic impact of Douglas Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Conrad more than expected).

Fields of papers citing papers by Douglas Conrad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Conrad. The network helps show where Douglas Conrad may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas Conrad Line = papers co-authored together Douglas Conrad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A GMR enzymatic assay for quantifying nuclease and peptidase activity Frontiers in Bioengineering and Biotechnology ·David Sulaiman Trivani Wijayansyah, Bru Zelius, Joshua V. Rosenberg, Douglas Conrad, Drew A. Hall, Anthony J. O’Donoghue	2024	2
2	Pathobiont-driven antibody sialylation through IL-10 undermines vaccination Journal of Clinical Investigation ·Chih‐Ming Tsai, Irshad A. Hajam, J.R. Caldera, Austin W.T. Chiang, Kabiru Kasamu Dawa, Xin Du, Taylor Hebert, Haining Li, E. Suzuki, Fatemeh Askarian, T.J.H. Clark, Brian Lin, Igor H. Wierzbicki, Angelica M. Riestra, Douglas Conrad, David J. Gonzalez, Victor Nizet, Nathan E. Lewis, George Y. Liu	2024	6
3	Is it time to end race and ethnicity adjustment for pediatric pulmonary function tests? Pediatric Pulmonology ·Amy L. Non, Kathryn Akong, Douglas Conrad	2023	3
4	Learning Models of Chest X-rays Accurately Segment Lung Parenchyma Independent of Datasets and Disease States Douglas Conrad, Kamyar Afshar, Ben Felts, Rajendar Gadkari, Barbara Bailey, Florence Aninniwaa Ahorsu	2023	1
5	Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis (InSPIRe:CF) – study protocol for a multicentre randomised clinical trial BMJ Open Respiratory Research ·Dolors Carnicer, Elisabeth P. Dellon, Anne L. Stephenson, Robert M. Arnold, Andrew D. Althouse, Kwonho Jeong, Zhiping Pan, Michiko Masuda, Joseph Christopher Pinon, Marie Bakitas, J L PUENTE, William F. Hunt, Sigrid Ladores, Kimberly Curseen, L. Koloszár, George M. Solomon, Jonathan Ailon, Douglas Conrad, Dio Kavalieratos	2022	3
6	Bone Marrow Transplantation Rescues Monocyte Recruitment Defect and Improves Cystic Fibrosis in Mice The Journal of Immunology ·Zhichao Fan, Elise Pitmon, Lai Wen, Jacqueline Miller, Erik Ehinger, Rana Herro, Wei Liu, Ju Chen, Zbigniew Mikulski, Douglas Conrad, Alex Márki, Marco Orecchioni, P. Hima Kumari, Yanfang Peipei Zhu, Paola Marcovecchio, Catherine C. Hedrick, Craig A. Hodges, Vijay Rathinam, Kepeng Wang, Klaus Ley	2022	9
7	Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry Annals of the American Thoracic Society ·Danieli B. Salinas, Choo Phei Wee, Barbara Bailey, Karen S. Raraigh, Douglas Conrad	2022	5
8	Automated CT Staging of Chronic Obstructive Pulmonary Disease Severity for Predicting Disease Progression and Mortality with a Deep Learning Convolutional Neural Network Radiology Cardiothoracic Imaging ·Kyle Hasenstab, سیده عشرت ایماندوست, Tara Retson, Douglas Conrad, Seth Kligerman, David A. Lynch, Albert Hsiao, (unknown)	2021	42
9	Tensin 1 ( TNS1 ) is a modifier gene for low body mass index (BMI) in homozygous [ F508del ]CFTR patients Physiological Reports ·Ch. K. Shao, Xijun Zhang, Anthony R. Soltis, Benjamin Boyar, Clifton L. Dalgard, Matthew D. Wilkerson, Douglas Conrad, Harvey B. Pollard	2021	2
10	Plasmonic Sensing Studies of a Gas-Phase Cystic Fibrosis Marker in Moisture Laden Air Sensors ·Mark Allen Taylor, Douglas Conrad, Drew A. Hall, Kurt D. Benkstein, Steve Semancik, Mona Zaghloul	2021	5
11	Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome International Journal of Molecular Sciences ·Cynthia B. Silveira, Ana G. Cobián-Güemes, Carla Uranga, Jonathon L. Baker, Anna Edlund, Forest Rohwer, Douglas Conrad	2021	17
12	Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients Journal of Cystic Fibrosis ·Douglas Conrad, Joanne Billings, Charlotte C. Tenebäck, Jonathan L. Koff, Daniel Rosenbluth, Barbara Bailey, Raksha Jain	2020	7
13	Smartphone-Based pH Sensor for Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis Sensors ·Alexander Sun, Sadettin Tosun, Chengyang Yao, Arjun K. Venkatesh, Douglas Conrad, Drew A. Hall	2017	15
14	Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients PLoS ONE ·Douglas Conrad, Barbara Bailey, Jon A. Hardie, Per Bakke, Tomas Eagan, Bernt B. Aarli	2017	11
15	Multidimensional Clinical Phenotyping of an Adult Cystic Fibrosis Patient Population PLoS ONE ·Douglas Conrad, Barbara Bailey	2015	18
16	β-Adrenergic Sweat Secretion as a Diagnostic Test for Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·Paul Quinton, Katherine Matsumoto-Gray, Wan Ip, Annie Dupuis, Julie Avolio, Elizabeth Tullis, Douglas Conrad, A. K. M. Shamsuddin, Peter R. Durie, Tanja Gonska	2012	76
17	Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa American Journal of Respiratory and Critical Care Medicine ·David E. Geller, Patrick A. Flume, Doris Staab, Rainald Fischer, Jeffery S. Loutit, Douglas Conrad	2011	118
18	Effects of inhaled MP-376 (aeroquin, levofloxacin inhalation solution) on lung function in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection Journal of Cystic Fibrosis ·Patrick A. Flume, David E. Geller, خشایار مرشد بهبهانی, Doris Staab, R. Fischer, Joachim Riethmüller, J. Loutit, Douglas Conrad	2010	18
19	HIA volume 26 Cover and Front matter History in Africa ·Douglas Conrad, Philip D. Curtin, J. D. Fage, P. E. H. Hair, Robin Law, J. Miller, Andrew Roberts, MICHAEL TWADDLE, Albert Van Dantzig, Amalina Fildzah Fujilestari, Aldo Stalin Naranjo Vargas, David Henige, (unknown)	1999	1
20	Foot education and screening programs for the elderly Journal of the American Podiatric Medical Association ·Mary Jane Schank, Douglas Conrad	1978	2

About Douglas Conrad

Douglas Conrad is a scholar working on Pulmonary and Respiratory Medicine, Space and Planetary Science, Endocrinology, Critical Care and Intensive Care Medicine and Emergency Medical Services, having authored 71 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (39 papers), Neonatal Respiratory Health Research (12 papers), Inhalation and Respiratory Drug Delivery (11 papers), Gut microbiota and health (9 papers), Asthma and respiratory diseases (8 papers), Tracheal and airway disorders (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Bacterial biofilms and quorum sensing (5 papers). The work is most often cited by research in Biochemistry (311 citations), Pulmonary and Respiratory Medicine (1.2k citations), Immunology (655 citations), Molecular Medicine (138 citations) and Molecular Biology (1.9k citations). Douglas Conrad has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Forest Rohwer, Yan Wei Lim, Elliott Sigal, Robert Schmieder, Mike Furlan, Colin Funk, John S. Welch, Christoph J. Binder, Timothy M. Willson and Joseph L. Witztum. Their work appears in journals such as Journal of Cystic Fibrosis, PLoS ONE, The ISME Journal, American Journal of Respiratory and Critical Care Medicine and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact